Skip to main content

Respiratory Syncytial Virus News

Related terms: Bronchiolitis, RSV

Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya

THURSDAY, April 17, 2025 — A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV), meningitis and a m...

Older Adults Have Low Knowledge of RSV Disease and Vaccine Eligibility

MONDAY, April 7, 2025 – Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, according to a study published online April 1 in...

COVID-19 Linked to More Severe Outcomes Than Flu, RSV in 2022-2023 Season

THURSDAY, Jan. 30, 2025 – COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season, according to a study published...

COVID-19 Remains Major Health Threat in U.S.

WEDNESDAY, Jan. 29, 2025 – COVID-19 continues to be a threat to America’s health, causing more illness and death than either influenza or respiratory syncytial virus (RSV), a new study suggests. C...

How To Fight Common Wintertime Respiratory Viruses

SATURDAY, Jan. 25, 2025 — In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you. Wash your hands often, cover your nose and mouth with a t...

Eight in 10 Infants Received RSV Protection in the 2023 to 2024 Season

WEDNESDAY, Jan. 8, 2025 – Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter published online Jan. 8 in JAMA ...

Immunocompromised Have Heterogeneous Antibody Response to RSV Vaccines

TUESDAY, Jan. 7, 2025 – For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about 40 percent do not seroconvert, according to a...

Confidence in Vaccines Both Steady and Rising in U.S. Adults

THURSDAY, Jan. 2, 2025 -- Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely accepted by the American public, while confidence in other ...

Has RSV Vaccine Hesitancy Subsided?

FRIDAY, Dec. 27, 2024 – More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory syncytial virus (RSV). More than half of U.S. adults...

RSVpreF Vaccine Effective in Preventing Severe RSV in Older Adults

WEDNESDAY, Dec. 18, 2024 – Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract disease (LRTD) among adults aged 60 years or older,...

RSV Burden Remains High in Young Children in the United States

WEDNESDAY, Dec. 11, 2024 – The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to a study published online Dec. 9 in JAMA...

Study Assesses Risk for 28-Day Hospitalization for Adults With RSV

WEDNESDAY, Nov. 20, 2024 – A number of adults with outpatient medically attended respiratory syncytial virus (MA-RSV) infection experience hospitalization within 28 days, with a higher proportion...

Optimal Timing of Maternal RSV Vaccine Determined to Be at Least Five Weeks Before Delivery

THURSDAY, Nov. 21, 2024 – Respiratory syncytial virus (RSV) vaccination at least five weeks prior to delivery results in the highest transplacental transfer of maternal antibodies to the neonate,...

RSV Hospitalizations Linked to Considerable Burden in Adults

FRIDAY, Nov. 15, 2024 – Respiratory syncytial virus (RSV) is associated with a considerable burden of hospitalizations, intensive care unit (ICU) admissions, and in-hospital deaths among adults,...

RSV Vaccination Prevents Associated Hospitalization, Emergency Encounters

THURSDAY, Nov. 7, 2024 – For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associated hospitalizations and emergency department encounters,...

Ask a question

To post your own question to our community, sign in or create an account.